Centralised Clinical Imaging Management AND Independent Image Analysis by Leading Experts
Innovative global imaging platform technology with Leading Specialist Consultants - the perfect combination for clinical trials
Choice TeleMed offers a full image management solution, from initial image upload to global multi-site encrypted transfers into a single imaging core lab with full specialist reader support - enabling CROs and Sponsors to access their images around the clock.
A single comprehensive system to quickly upload, archive, analyse, and read trial imaging
Reputation and credibility
Medical imaging now plays a vital role in clinical trials with demand ever increasing with innovation tech like Imaging AI tools. The complexity of imaging endpoints within trials requires a robust web and cloud enabled technological solution to cover multiple dispirit sites as well as assist in the actual reads.
Reputation and credibility in Clinical Trials are paramount. Confidence is key which demands the highest quality specialists with unbiased and professional imaging support.
Reader performance is the most critical component in establishing drug or device efficacy. Our reporting is of the highest standards in the world, with award-winning experts having over 450 publications and research collaborations. All images are reported by UK specialist Consultant radiologists to the latest GDPR standards.
At Choice, we have 2 USPs - the most innovative global imaging platform technology, and Leading Specialist Consultants - the perfect combination for clinical trials
Choice TeleMed is a unique Imaging CRO. We can manage multi-site, cross border imaging studies faster, cheaper, and with lower risk. We provide cloud-based, secure management for all your medical imaging tasks in an innovative and intuitive system. Improve visibility and access while simplifying processes for sites, sponsors, and core labs alike.
We pride ourselves in Clinical Trials Imaging and on only providing the best and most reputable radiologists for single, double, peer review and adjudication reviews included in Phase I-III Clinical Trials and Class I, II, and III Medical Device Trials.
· Trial bid imaging quotes
· Scan protocol imaging manual design
· Bid defence support
· Urgent Medical Physics Expert and Clinical Radiation Expert (MPE & CRE) reviews
· Global image management system (with blinding)
· Expert reading/reporting for leading KOLs
· AI integration - Leverage an AI read into your trial with our secure bespoke solution
Whether you're a large Pharma company, a CRO, academic institution or hospital research/trials unit, Choice TeleMed can provide your complete clinical trial imaging needs.
Agile, responsive, and with a smile on our face because we love our work
Clinical Trials Imaging and Artificial Intelligence - Eliminate Bias, Improve Accuracy, Reduce Cost
Cost Reduction. Clinical trial scans are routinely reviewed by 2 readers with often a 3rd for adjudication (2+1 model). Collectively these resources can be costly particularly with any significant volumes and timepoints. One potential way to save on cost is to introduce AI to perform one of the reads. Hence the first reader is AI at a cost reduction, the second reader is still a radiologist.
Improve Accuracy. Single read clinical radiology accuracy rates are generally thought to be @85%. The introduction of a second reader and
adjudicator can raise that up to @95% common in clinical trials. The potential of AI is also to introduce a further layer on top as a 3rd (or 4th)
reed, hence pushing the accuracy rate up further above 97/98%.
Collect more data. If the objective of the trial is to collect as much qualitative and quantitative data as possible, the introduction of AI can produce more structured outcomes and assist with incident findings.
Add an AI read to to your 2+1 model in a safe and efficient manor to enable a 2+1+1 super model while simultaneously collecting more data and adding another layer of outcome validation and accuracy.
‘Choice TeleMed was invaluable in providing site solutions in order for us to secure grant funding. Choice clearly has the expertise to support and expand any site’s study feasibility by providing the specialist image analysis. Choice tapped its expansive network of experts in sophisticated pulmonary image analysis to help us partner with various sites to trial our ground-breaking AI pulmonary nodule detection software. The sheer breadth of AI imaging knowledge and enthusiasm that Choice management brings is refreshing and we welcome working with Choice again in future’.
JvD, COO - Leading AI Vendor